Archives

by in
Entry Author Date Location
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
Clovis Shares Tumble as Analysts Give Edge to Lung-Cancer Rival 06/04/14 Boulder/Denver
Labrys Turns Stalled Pfizer Program into $200M+ Teva Buyout 06/03/14 San Francisco
Promedior Sees Hope in Small Myelofibrosis Study 05/30/14 Boston
Twist Bio Aims for Better DNA Synthesis With Silicon Engineering 05/27/14 San Francisco
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
EU Reverses Course on PTC Drug, Shares Boom 05/23/14 New York
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
Ophthotech, Novartis Team up on $1B Deal for Eye Drug 05/19/14 New York
Shire Pays Over $260M Upfront in IPO Detour for San Diego’s Lumena 05/12/14 National
Tesaro Climbs on Phase 3 Data for Nausea Drug 05/12/14 Boston
Radius Health Yanks IPO, Cites Market Conditions 05/09/14 Boston
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
San Diego’s Synthorx Adds To Genetic Alphabet, Aims for Bio-Products 05/07/14 San Diego
Rhythm Eyes Pivotal Study as GI Drug for Diabetics Hits Phase 2 Mark 05/06/14 Boston
San Diego’s Ambrx Files for IPO to Advance Antibody-Drug Conjugates 05/05/14 San Diego
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
San Diego Life Sciences Roundup: Otonomy, Verdezyne, and IPOs 05/02/14 San Diego
Wireless Health Summit: Barriers to Adoption and Tools for Change 05/01/14 San Diego
Merrimack Heads to FDA as Pancreatic Cancer Drug Succeeds in Phase 3 05/01/14 Boston
Otonomy Raises $49M to Advance 3 Drugs for Treating Ear Diseases 04/30/14 San Diego
BioPharma Learns From Marvel, Begins Real Life Search For “X-Men” 04/30/14 Seattle
OncoGenex’s Long Wait For Cancer Drug Ends With a Phase 3 Stumble 04/28/14 Seattle
Amid Court Fight and Trial Pauses, Juno Closes First Round at $176M 04/24/14 Seattle
San Diego Life Sciences Roundup: Illumina, Vital Therapies, and More 04/24/14 San Diego
Sarepta to Submit Application for Duchenne Drug, Shares Boom 04/21/14 Boston
Vyrix Files for $29M IPO to Develop Anti-Premature Ejaculation Drug 04/18/14 Boulder/Denver
VCs Invest $243M in San Diego Startups in Q1, Tech Drought Continues 04/18/14 San Diego
Overstreet, Winner in Startup Tax Battle, Gets $2M for AdverseEvents 04/16/14 San Francisco
Page 4 of 80 « previous page · next page »